http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-201929892-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_64a8f9dfac855d6e43cbd7a7e1b90871 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 2018-01-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cea874b33d08efc991d5dd78833a4136 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9b95113a52ee5093b0da2a1429732f5d |
| publicationDate | 2019-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | TW-201929892-A |
| titleOfInvention | Use of a peptide structure for preparing anti-inflammatory, anti-cancer and anti-tumor compositions |
| abstract | The invention discloses a use of Patek Xin to prepare anti-inflammatory, anti-cancer and anti-tumor compositions, and has the following effects: 1. Stimulating common blood cell precursor cells and inducing activation of T cell proliferation; 2. Activate MAPK Further, it promotes the maturation of bone marrow-derived dendritic cells; third, the pathway that promotes cancer cells to undergo apoptosis; fourth, the phenomenon of inhibiting metastasis of cancer cells; and fifth, has the function of promoting AMPK activity. |
| priorityDate | 2018-01-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 71.